Phibro Animal Health | PAHC - 营业费用

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.27B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	营业费用	更改		日
Align Technology	USD 862.03M		39.18M	2026-03
ANI Pharmaceuticals	USD 562.3M		344.37M	2026-03
Assertio Holdings	USD 105.8M		12.5M	2025-09
Aurora Cannabis	CAD 129.98M		16.05M	2025-12
Bristol-Myers Squibb	USD 20.07B		11.77B	2026-03
Canopy Growth	CAD 87.2M		6.22M	2025-12
Corcept Therapeutics	USD 214.5M		16.87M	2026-03
Eli Lilly	USD 10.02B		285M	2026-03
Henry Schein	USD 3.17B		77M	2026-03
Idexx Laboratories	USD 778.23M		3.26M	2026-03
Knight Therapeutics	CAD 126.9M		8.29M	2025-12
Merck	USD 18.17B		8.01B	2026-03
Nektar Therapeutics	USD 40.9M		44.19M	2025-12
Pacira	USD 172.75M		20.93M	2026-03
Phibro Animal Health	USD 361.83M		29.47M	2026-03
Prestige Brands	USD 206.12M		5.17M	2026-03
Supernus Pharmaceuticals	USD 1.08B		879.06M	2026-03
Zoetis	USD 3.23B		1.68B	2026-03